Apham SA
0.5 FTEApham reported total assets of 398,276 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Jun 2026), with 0.5 full-time equivalent.
The score of Apham shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -45 % Total assets +9 % Headcount (avg FTE) -50 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apham's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 29 Jul 2022
Apham's financial analysis
- Solvency36.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apham
Apham's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0414.244.042
- VAT number
- BE0414244042
- Peppol
- Registered · 0208:0414244042 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Jun 1974
- Registered office
- 2660 Antwerp
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 11 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apham (SA) has been based in Antwerp since 1974, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 961 € and equity of 146,406 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 36.8%, below the median of its sector (44.2%).
Companies similar to Apham
Companies in the same business, of comparable size and area, outside its group.
- Apotheek P. Hostens Retail sale of pharmaceutical products Antwerp · balance sheet 738,383 €
- Pharmacie Arnaud Nicolas Retail sale of pharmaceutical products Ixelles · balance sheet 161,036 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Smets Pharma Retail sale of pharmaceutical products Lier · balance sheet 452,862 €
- Temmerman Retail sale of pharmaceutical products Ghent · balance sheet 349,257 €
- Medicuro Retail sale of pharmaceutical products Stekene · balance sheet 457,159 €
- I & CM Patriotes Retail sale of pharmaceutical products Brussels · balance sheet 322,247 €
- LNR Retail sale of pharmaceutical products Kasterlee · balance sheet 516,544 €
Frequently asked questions about Apham
What is the revenue of Apham?
Apham files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apham?
In Belgium, the VAT number is the company number prefixed with BE: BE0414244042 for Apham, if the company is VAT-registered. Its company number (CBE) is 0414.244.042.
Where is the registered office of Apham?
According to the CBE register, the registered office of Apham is in 2660 Antwerp.
What is the equity of Apham?
At the close of the 2025 financial year, the equity of Apham amounts to 146,406 €, a solvency of 36.8% of total assets.
How many people work at Apham?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apham?
The register lists 3 active mandates at Apham. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apham
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →